Aemetis (NASDAQ:AMTX) Upgraded by StockNews.com to Sell Rating

StockNews.com upgraded shares of Aemetis (NASDAQ:AMTX) to a sell rating in a research report released on Wednesday morning.

AMTX has been the subject of several other reports. Ascendiant Capital Markets lowered their price objective on shares of Aemetis from $20.00 to $19.00 and set a “buy” rating for the company in a research report on Tuesday, September 3rd. HC Wainwright reissued a “buy” rating and set a $28.00 target price on shares of Aemetis in a research note on Monday. One analyst has rated the stock with a sell rating, one has assigned a hold rating and four have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $12.95.

Aemetis Stock Performance

Shares of AMTX stock opened at $2.63 on Wednesday. The stock’s 50 day simple moving average is $3.29 and its 200 day simple moving average is $2.99. Aemetis has a twelve month low of $2.10 and a twelve month high of $7.03. The company has a market capitalization of $130.80 million, a price-to-earnings ratio of -1.16 and a beta of 1.35.

Aemetis (NASDAQ:AMTX) last issued its quarterly earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.47) by $0.09. The company had revenue of $81.44 million during the quarter, compared to the consensus estimate of $77.79 million. During the same period last year, the company earned ($0.59) earnings per share. On average, analysts forecast that Aemetis will post -2.02 EPS for the current fiscal year.

Institutional Trading of Aemetis

Several large investors have recently modified their holdings of the stock. FMR LLC lifted its position in shares of Aemetis by 68.2% during the 3rd quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock worth $52,000 after buying an additional 9,137 shares during the last quarter. Hutchinson Capital Management CA bought a new position in shares of Aemetis in the second quarter worth about $70,000. Barclays PLC boosted its stake in shares of Aemetis by 274.6% in the 3rd quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock valued at $109,000 after purchasing an additional 34,816 shares in the last quarter. Rhumbline Advisers increased its position in Aemetis by 2,837.1% during the 2nd quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after purchasing an additional 50,528 shares in the last quarter. Finally, Wellington Management Group LLP acquired a new position in Aemetis during the 3rd quarter worth approximately $177,000. 27.02% of the stock is owned by institutional investors and hedge funds.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.